Houston, TX - Using enoxaparin or heparin to bridge long-term anticoagulation therapy with warfarin for secondary stroke prevention has been associated with a high risk for serious bleeding in ...

A simple-to-use strategy that prevents blood clots in patients who have suffered a heart attack markedly reduces the risk of repeat heart attack or death when compared to an older, more widely used ...

The IV heparin recommended by Peter F. Cohn, MD, as bridging therapy when warfarin has to be stopped in a pa-tient with an artificial heart valve (Item 99-12) requires a long hospital stay. Why not ...

Effects of admission (adm) source, time, and provider on inpatient (inpt) oncology (onc) outcomes at the Cleveland Clinic Foundation (CCF).

Objectives: To compare the safety and effectiveness of two different thromboprophylactic protocols in the management of patients with spinal cord injury – one using heparin/warfarin and the other ...

Enoxaparin is an anticoagulant medication that helps effectively prevent the formation of blood clots. Used in patients with deep-vein thrombosis, acute coronary syndrome, heart attacks and pulmonary ...

Results showed direct factor Xa inhibitor was less likely to elevate liver damage markers. Daiichi Sankyo reported data from a Phase III trial demonstrating that its once-daily, oral direct factor Xa ...

Aspirin alone doesn’t seem to be enough to prevent symptomatic venous thromboembolism (VTE) in the months following total hip or knee replacement for osteoarthritis, results of the CRISTAL trial ...

To read this article for CME, click here. July 18, 2008 — Using enoxaparin or heparin to bridge long-term anticoagulation therapy with warfarin for secondary stroke prevention has been associated with ...